Accolade Statistics
Total Valuation
PCRHY has a market cap or net worth of 23.25 billion. The enterprise value is 28.79 billion.
| Market Cap | 23.25B |
| Enterprise Value | 28.79B |
Important Dates
The last earnings date was Monday, July 28, 2025.
| Earnings Date | Jul 28, 2025 |
| Ex-Dividend Date | Sep 29, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 2.27B |
Valuation Ratios
The trailing PE ratio is 9.14.
| PE Ratio | 9.14 |
| Forward PE | n/a |
| PS Ratio | 0.41 |
| PB Ratio | 0.70 |
| P/TBV Ratio | 0.73 |
| P/FCF Ratio | 2,514.02 |
| P/OCF Ratio | 4.48 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.13, with an EV/FCF ratio of 3,113.97.
| EV / Earnings | 11.32 |
| EV / Sales | 0.52 |
| EV / EBITDA | 5.13 |
| EV / EBIT | 9.93 |
| EV / FCF | 3,113.97 |
Financial Position
The company has a current ratio of 1.29, with a Debt / Equity ratio of 0.33.
| Current Ratio | 1.29 |
| Quick Ratio | 0.79 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 1.93 |
| Debt / FCF | 1,169.10 |
| Interest Coverage | 12.96 |
Financial Efficiency
Return on equity (ROE) is 7.85% and return on invested capital (ROIC) is 3.91%.
| Return on Equity (ROE) | 7.85% |
| Return on Assets (ROA) | 2.66% |
| Return on Invested Capital (ROIC) | 3.91% |
| Return on Capital Employed (ROCE) | 6.20% |
| Revenue Per Employee | 274,951 |
| Profits Per Employee | 12,257 |
| Employee Count | 207,548 |
| Asset Turnover | 0.86 |
| Inventory Turnover | 4.77 |
Taxes
In the past 12 months, PCRHY has paid 605.17 million in taxes.
| Income Tax | 605.17M |
| Effective Tax Rate | 18.48% |
Stock Price Statistics
The stock price has increased by +22.17% in the last 52 weeks. The beta is 0.74, so PCRHY's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | +22.17% |
| 50-Day Moving Average | 10.41 |
| 200-Day Moving Average | 10.52 |
| Relative Strength Index (RSI) | 36.38 |
| Average Volume (20 Days) | 209,833 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PCRHY had revenue of 57.07 billion and earned 2.54 billion in profits. Earnings per share was 1.09.
| Revenue | 57.07B |
| Gross Profit | 18.03B |
| Operating Income | 2.82B |
| Pretax Income | 3.28B |
| Net Income | 2.54B |
| EBITDA | 5.60B |
| EBIT | 2.82B |
| Earnings Per Share (EPS) | 1.09 |
Balance Sheet
The company has 6.32 billion in cash and 10.81 billion in debt, giving a net cash position of -4.49 billion.
| Cash & Cash Equivalents | 6.32B |
| Total Debt | 10.81B |
| Net Cash | -4.49B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 33.02B |
| Book Value Per Share | 13.63 |
| Working Capital | 5.43B |
Cash Flow
In the last 12 months, operating cash flow was 5.19 billion and capital expenditures -5.18 billion, giving a free cash flow of 9.25 million.
| Operating Cash Flow | 5.19B |
| Capital Expenditures | -5.18B |
| Free Cash Flow | 9.25M |
| FCF Per Share | n/a |
Margins
Gross margin is 31.59%, with operating and profit margins of 4.94% and 4.46%.
| Gross Margin | 31.59% |
| Operating Margin | 4.94% |
| Pretax Margin | 5.74% |
| Profit Margin | 4.46% |
| EBITDA Margin | 9.81% |
| EBIT Margin | 4.94% |
| FCF Margin | 0.02% |
Dividends & Yields
This stock pays an annual dividend of 0.32, which amounts to a dividend yield of 3.37%.
| Dividend Per Share | 0.32 |
| Dividend Yield | 3.37% |
| Dividend Growth (YoY) | 24.98% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 30.53% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 3.36% |
| Earnings Yield | 10.94% |
| FCF Yield | 0.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PCRHY has an Altman Z-Score of 2.1 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.1 |
| Piotroski F-Score | 5 |